BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26812941)

  • 1. Donors' health state the year after peripheral haematopoietic progenitor cell collection: A prospective follow-up study in related and unrelated donors compared to first-time platelet donors.
    Bank I; Wiersum-Osselton JC; Van Walraven SM; Netelenbos T; Fechter M; Marijt-van der Kreek T; Bär BM; Van der Bom JG; Brand A
    J Clin Apher; 2016 Dec; 31(6):523-528. PubMed ID: 26812941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior blood donations do not affect efficacy of G-CSF mobilization nor outcomes of haematopoietic stem cell collection in healthy donors.
    Pruszczyk K; Bartnik K; Bogusz K; Farhan R; Cwil D; Jastrzębska A; Moskowicz A; Płachta M; Chmiel A; Skwierawska K; Urbanowska E; Jędrzejczak WW; Snarski E
    Vox Sang; 2019 Aug; 114(6):622-627. PubMed ID: 31168814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
    Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
    Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.
    Martino M; Console G; Dattola A; Callea I; Messina G; Moscato T; Massara E; Irrera G; Fedele R; Gervasi A; Bresolin G; Iacopino P
    Bone Marrow Transplant; 2009 Aug; 44(3):163-8. PubMed ID: 19182833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study.
    Tassi C; Tazzari PL; Bonifazi F; Giudice V; Nannetti A; Ricci F; Rizzi S; Bandini G; Conte R
    Bone Marrow Transplant; 2005 Aug; 36(4):289-94. PubMed ID: 15968277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.
    Flommersfeld S; Sohlbach K; Jaques G; Bein G; Hoffmann J; Kostrewa P; Sachs UJ
    Transfusion; 2015 Jun; 55(6):1269-74. PubMed ID: 25647638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective.
    Gordon SV; Nivison-Smith I; Szer J; Chapman JR
    Intern Med J; 2013 Nov; 43(11):1183-90. PubMed ID: 24007325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful collection and engraftment of autologous peripheral blood progenitor cells in poorly mobilized patients receiving high-dose granulocyte colony-stimulating factor.
    Cooper DL; Proytcheva M; Medoff E; Seropian SE; Snyder EL; Krause DS; Wu Y
    J Clin Apher; 2012 Nov; 27(5):235-41. PubMed ID: 22566214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study.
    Bertani G; Santoleri L; Martino M; Fedele R; Moscato T; Marenco P; Grillo G; Zucchetti E; Lotesoriere I; Lando G; Cesana C; Cairoli R; Rossini S
    Transfusion; 2014 Aug; 54(8):2028-33. PubMed ID: 24588265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell mobilization and collection from pediatric patients and healthy children.
    Karakukcu M; Unal E
    Transfus Apher Sci; 2015 Aug; 53(1):17-22. PubMed ID: 26116046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.
    Martino M; Bonizzoni E; Moscato T; Recchia AG; Fedele R; Gallo GA; Console G; Messina G; Morabito F
    Biol Blood Marrow Transplant; 2015 May; 21(5):881-8. PubMed ID: 25636377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
    Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
    Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
    Zhang S; Jin H; Xu LP; Liu DH; Chen H; Liang YQ; Li T; Li FX; Wang R; Kang Q; Chen YH; Zhang XH; Han W; Huang XJ; Liu KY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1017-22. PubMed ID: 20723320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of laboratory tests to guide initiation of autologous hematopoietic progenitor cell collection by apheresis: results from the multicenter hematopoietic progenitor cell collection by Apheresis Laboratory Trigger Survey.
    Makar RS; Padmanabhan A; Kim HC; Anderson C; Sugrue MW; Linenberger M
    Transfus Med Rev; 2014 Oct; 28(4):198-204. PubMed ID: 25311468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization and collection of peripheral blood stem cells in healthy donors: risks, adverse events and follow-up.
    Moalic V
    Pathol Biol (Paris); 2013 Apr; 61(2):70-4. PubMed ID: 23199456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor increases the platelet volume in peripheral stem cell apheresis donors.
    Ihara A; Matsui K; Minami R; Uchida S; Ueda S; Nishiura T
    Pathophysiol Haemost Thromb; 2008; 36(5):266-70. PubMed ID: 19996637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of cell kinetics, yields and donor experiences during a single large-volume apheresis versus two smaller volume consecutive day collections of allogeneic peripheral blood stem cells.
    Bolan CD; Carter CS; Wesley RA; Yau YY; Barrett AJ; Childs RW; Read EJ; Leitman SF
    Br J Haematol; 2003 Mar; 120(5):801-7. PubMed ID: 12614213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.